Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBASP versus escitalopram in chronic major depression with and without early trauma
2007-006914-41Phase 4Active
- Sponsor
- University of Freiburg
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of escitalopram in major depressive disorder (MDD) (2 arms), sponsored by University of Freiburg. Primary endpoint: MADRS score at week 8. Started Aug 2009; status: active.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2007-006914-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006914-41.